SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Bristol Myers Squibb
Bristol Myers Squibb
Page 2 of 3
Health
Diversity is long overdue in the drug industry—and it’s going to take more than just hiring Black candidates
By
Sy Mukherjee
August 12, 2020
Newsletters
Healthcare is in the midst of a ‘paradigm shift’
By
Katherine Dunn
and
Alan Murray
July 8, 2020
Conferences
Will the pharmaceutical industry keep collaborating after COVID-19? Novartis and Bristol Myers Squibb CEOs say it has to
By
David Z. Morris
July 7, 2020
Health
5 companies to keep an eye on following the world’s largest cancer conference
By
Sy Mukherjee
June 3, 2020
Newsletters
Fitbit Teams Up With Drug Giants to Tackle a Serious Heart Condition: Brainstorm Health
By
Sy Mukherjee
October 17, 2019
Newsletters
The FDA Went on an Epic Drug Approval Binge This Week: Brainstorm Health
By
Sy Mukherjee
August 16, 2019
Health
Bristol-Myers Squibb Loses $6 Billion in Value on Celgene Deal Setback: Brainstorm Health
By
Sy Mukherjee
June 24, 2019
Bristol-Myers Is Buying Celgene for $74 Billion in One of the Largest Big Pharma Mergers Ever
By
Bloomberg
January 3, 2019
Health
A Cancer Blockbuster Gets Approved in China. Will the Floodgates Now Open?
By
Clifton Leaf
June 15, 2018
Health
Merck’s Bet on Cancer Immunotherapy Is Paying Off in Spades and Helping Lung Cancer Patients Live Longer
By
Sy Mukherjee
April 16, 2018
Health
This Lung Cancer Drug Could Let Patients Forgo Chemo—And It’s Sending Merck’s Stock Soaring
By
Sy Mukherjee
April 9, 2018
Health
Why Cancer Drug Maker Incyte’s Stock Plunged—And Took Others Down With It
By
Sy Mukherjee
April 6, 2018
Health
Bristol-Myers Squibb Shares Just Spiked on Reports of a Carl Icahn Stake
By
Sy Mukherjee
February 21, 2017
Health
Why These Two Pharma Stocks Are Having Drastically Different Days
By
Sy Mukherjee
January 20, 2017
Health
Why Pharma Giant Bristol-Myers Squibb’s Shares Took a Big Hit Today
By
Sy Mukherjee
October 10, 2016
Most Popular
Success
Multimillion-dollar restaurant CEO used to splurge on Range Rovers and McLarens—but he’s reining it in now because...
By
Emma Burleigh
Success
Millionaire Alexis Ohanian walked out of the LSAT 20 minutes in, went to a Waffle House, and decided he was ‘gonna...
By
Preston Fore
Tech
‘Yes, you read that correctly’: Tesla pay committee pitches $1 trillion pact to keep Elon Musk as CEO for long term
By
Nick Lichtenberg